PA5-16534

antibody from Invitrogen Antibodies

Targeting: BIRC5 API4, EPR-1, survivin

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

PA5-16534

Provider

Invitrogen Antibodies

Product name

Anti-Survivin Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

PA5-16534 targets Survivin in IHC (P) applications and shows reactivity with mouse and Human samples. The PA5-16534 immunogen is a synthetic peptide derived from the C-terminus of survivin.

Reactivity

Human, Mouse

Host

Rabbit

Isotype

IgG

Vial size

500 µL

Concentration

1 mg/mL

Storage

4° C

References

Submitted references

Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression.

Kim SA, Hong R
Oncology letters 2014 May;7(5):1589-1593

---

Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.

Farnebo L, Tiefenböck K, Ansell A, Thunell LK, Garvin S, Roberg K
International journal of cancer 2013 Oct 15;133(8):1994-2003

---

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma.

Park KW, Jung ES, Kim DG, Yoo YK, Hong TH, Lee IS, Koh YH, Kim JH, Lee MA
Cancer research and treatment : official journal of Korean Cancer Association 2013 Mar;45(1):63-9

---

Immunohistological analysis of cell cycle and apoptosis regulators in thymus.

Bai M, Doukas M, Papoudou-Bai A, Barbouti A, Stefanaki K, Galani V, Kanavaros P
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 2013 Mar;195(2):159-65

---

Prognostic significance of Bcl-2, tumor-associated macrophages, and total neoplastic and inflammatory lymph node involvement in advanced stage classical Hodgkin's lymphoma.

Jakovic LR, Mihaljevic BS, Jovanovic MD, Bogdanovic AD, Andjelic BM, Bumbasirevic VZ
Onkologie 2012;35(12):733-9

---

Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer.

Wang M, Liu BG, Yang ZY, Hong X, Chen GY
Experimental and therapeutic medicine 2012 Jun;3(6):983-988

---

Clinicopathological significance of cathepsin D expression in non-small cell lung cancer is conditional on apoptosis-associated protein phenotype: an immunohistochemistry study.

Fan C, Lin X, Wang E
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Aug;33(4):1045-52

---

Expression profiles of p63, p53, survivin, and hTERT in skin tumors.

Park HR, Min SK, Cho HD, Kim KH, Shin HS, Park YE
Journal of cutaneous pathology 2004 Sep;31(8):544-9